Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

HealthEquity (HQY) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

HealthEquity (HQY) reported earnings 30 days ago. What's next for the stock?

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

The consensus price target hints at a 31.4% upside potential for HealthEquity (HQY). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings es...

HealthEquity's (HQY) strength in HSA raises optimism about the stock.

HealthEquity, Inc. (NASDAQ:HQY ) Q3 2024 Earnings Conference Call December 5, 2023 4:30 PM ET Company Participants Richard Putnam - Investor Relations Jon Kessler - President and Chief Executive Of...

HealthEquity (HQY) came out with quarterly earnings of $0.60 per share, beating the Zacks Consensus Estimate of $0.49 per share. This compares to earnings of $0.38 per share a year ago.

While the top- and bottom-line numbers for HealthEquity (HQY) give a sense of how the business performed in the quarter ended October 2023, it could be worth looking at how some of its key metrics ...

HealthEquity (HQY) reached a significant support level, and could be a good pick for investors from a technical perspective. Recently, HQY broke through the 20-day moving average, which suggests a ...

Get a deeper insight into the potential performance of HealthEquity (HQY) for the quarter ended October 2023 by going beyond Wall Street's top -and-bottom-line estimates and examining the estimates...

HealthEquity has seen its share price trade sideways in 2023 but has the potential for long-term growth with certain competencies. Q2 earnings showed an 18% increase in revenue and strong asset gro...

Finding stocks expected to beat quarterly earnings estimates becomes an easier task with our Zacks Earnings ESP.

Here is how HealthEquity (HQY) and Corbus Pharmaceuticals (CRBP) have performed compared to their sector so far this year.

Some of the most followed information in the stock market besides earnings releases are analyst recommendations. These are expert analyses that cover various companies that have a high potential fo...